In this regard, chronic administration of roxadustat to a mouse model of angiotensin II-induced hypertension has been shown to suppress hypertension and kidney damage through eNOS activation associated with HIF stabilization [56] and even showed a slight reduction in blood pressure and cardiovascular protection [59,60]. The gene discussed is AGT; the disease is hypertensive disorder.